Abstract
The successful integration of dental implants relies on osseointegration, a process essential for implant stability and longevity. Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) have gained attention as biological enhancers for this process due to their high concentrations of growth factors that promote bone regeneration and accelerate healing. This review assesses the efficacy of PRP and PRF in enhancing osseointegration by exploring their biological mechanisms, clinical applications, and advantages for patients with compromised bone or healing potential. Literature indicates that PRP and PRF can improve initial implant stability and accelerate healing. PRP's platelet-derived growth factors (e.g., PDGF, TGF-β, VEGF) stimulate cellular proliferation and angiogenesis, critical for early bone healing. PRF's fibrin-rich matrix provides a sustained release of these factors, supporting prolonged tissue regeneration and soft tissue repair. However, challenges remain, including variability in preparation methods and limited long-term data, underscoring the need for standardized protocols and further research. In conclusion, PRP and PRF demonstrate promise as adjuncts for enhancing dental implant osseointegration, particularly in complex cases. With more evidence and established protocols, they have the potential to become standard tools in implant dentistry, offering improved outcomes and greater predictability in patient care.